Medical Tourism in Tennessee

The reality of medical tourism is becoming more prevalent with each passing day. The advancements in medical technology has created specialized clinics all over the world for people seeking individualized treatment. Tennessee has become a hub for medical tourism due to its cultural sites and vibrant medical community. Next time you’re interested in traveling for medical reasons, why not choose a place that can offer you a large number of attractions ranging from the country music capital of the world to historical Civil War memorials? If you have a lung disease like chronic obstructive pulmonary disease (COPD) or interstitial lung disease, consider visiting Nashville and the Lung Institute for treatment.

Lung Institute Tennessee

The Lung Institute is a leading global provider of innovative regenerative medicine technologies for the treatment of an array of debilitating lung and pulmonary conditions. We are committed to an individualized patient-centric approach, which consistently provides the highest quality of care and produces positive outcomes. By applying modern-day best practices to the growing field of regenerative medicine, the Lung Institute is improving lives.

Stem Cell Treatment for Lung Disease

The Lung Institute utilizes autologous stem cells, derived from the patient’s own body for both the venous (blood-derived) and bone marrow stem cell procedures. During these procedures, stem cells are extracted, isolated and then immediately introduced back into the body where they then divide and replicate into healthy cells specialized to the damaged tissue. The use of autologous stem cells in transplantation is considered to be more reliable than stem cells from another individual as there is a much lower probability of rejection due to the fact that autologous stem cells are derived from the patient’s own body. Both bone marrow and venous stem cells have shown anti-inflammatory properties beneficial to patients with lung disease.

Autologous stem cells are derived from the patient’s own blood or bone marrow, are isolated, and are given back to the patient intravenously or through the use of a nebulizer.

Dr. James St. Louis

James St. Louis, DO, is the chief medical officer at the Lung Institute. He completed his orthopaedic residency in the U.S. Army, and provided dedicated service at Fort Lewis and the Kennedy Medical Center. After years of intensive training in orthopaedics, he was named medical director of Health South in Pensacola, Florida, where he also established the Pensacola Clinic Bone and Joint Center. He went on to serve as chief of surgery at Woodland Medical Center in Cullman, Alabama.

“If you’re a patient just imagine not being able to wake up in the morning and walk into the kitchen, check the mail or go on a walk with your spouse. This is what our patients are suffering from,” St. Louis said. “When they call us, they come in and we utilize an autologous process that uses their own stem cells, which makes it safe and effective for the patient. (There is) also a minimal chance of the stem cells being rejected because it’s the patients’ own cells. We then process the cells, and re-inject them back into the patient through the use of an IV or nebulizer. The process takes about 3 days. The patients typically comment on how easy it was for them, and certainly a lot easier than they might have expected.”

If you or a loved one has a lung disease and you’re looking to utilize the growing industry of medical tourism, consider getting treatment at the Lung Institute.  If you want to learn more about treatment options, please contact us or call (800) 729-3065 today.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.